Literature DB >> 1959786

In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell line.

M A Schiano1, B U Sevin, J Perras, R Ramos, E H Wolloch, H E Averette.   

Abstract

Cell kinetic perturbations measuring DNA and nuclear protein with dual-parameter flow cytometry were studied in vitro after cis-platinum (DDP) treatment of a DDP-resistant human ovarian cell line (BG-1). Cell viability (trypan blue exclusion) and the cell's ability to replicate (replicating potential) are also reported. A dose-dependent G2 arrest and concomitant increase in cytotoxicity were observed. We also observed a marked increase in cytotoxicity of 2.5 micrograms/ml DDP with the addition of 1 mM of caffeine (CAF) or pentoxifylline (PTX). Additionally, the cells treated with DDP and CAF or DDP and PTX demonstrated a markedly diminished ability to replicate. Cell cycle perturbations, especially the G2-phase arrest, were markedly enhanced in the cells treated with DDP and CAF or DDP and PTX, when compared to that in cells treated with DDP alone. We conclude that the cytotoxicity of DDP is enhanced by CAF and PTX in vitro by inhibiting DNA repair during the S and G2 phases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959786     DOI: 10.1016/0090-8258(91)90006-q

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Developmental toxicity of orally administered sildenafil citrate (Viagra) in SWR/J mice.

Authors:  Faisal Mohamed Abou-Tarboush; Mohamed Fathy Abdel-Samad; Mokhlid Hamed Al-Meteri
Journal:  Saudi J Biol Sci       Date:  2010-12-23       Impact factor: 4.219

2.  A novel model of a metastatic human breast tumour xenograft line.

Authors:  J Hurst; N Maniar; J Tombarkiewicz; F Lucas; C Roberson; Z Steplewski; W James; J Perras
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

3.  Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.

Authors:  K Kasahara; M Fujimura; T Bando; K Shibata; H Shirasaki; T Matsuda
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

4.  Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.

Authors:  Y Sadzuka; A Iwazaki; A Miyagishima; Y Nozawa; S Hirota
Journal:  Jpn J Cancer Res       Date:  1995-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.